Standing Issue Threatens 15 Zometa Suits In NJ

Law360, New York (December 2, 2013, 2:30 PM EST) -- A New Jersey judge has dismissed 15 lawsuits over Novartis Pharmaceuticals Corp.'s bone-strengthening drug Zometa, based on a failure to file certain documents intended to show that the cases belonged in the multicounty litigation.

Judge Jessica Mayer said in an order issued Nov. 19 that plaintiffs' counsel were required to file affidavits or certifications with Middlesex County Superior Court to indicate that each case had a real party in interest with standing, which the 15 named cases had failed to do.

The judge dismissed the cases without prejudice and said Novartis had 60 days to to file motions to knock the...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Attached Documents

Related Sections

Law Firms

Companies

Government Agencies

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!